Advanced Search

 

Study ID Status Title Patient Level Data
OXS107714 Completed A multi-centre, randomized, double-blind, placebo-controlled, cross-over study to evaluate the effects of SB-649868 (10, 30 mg and 60 mg) on sleep continuity, PSG sleep recordings, subjective sleep assessment, and daytime cognitive function in subjects with primary insomnia
OXS109139 Completed An open-label study to determine the excretion, balance and pharmacokinetics of SB649868 after a single oral administration of 14C-SB649868 in healthy volunteers
P02-027 Completed A Single Dose Metabolism Study of 14C-Wellbutrin in Normal Volunteers
P02-24 Completed Phase I - A comparison of bupropion, dextroamphetamine and placebo for abuse liability in amphetamine abusers
P02-31UK Completed Examination of Bupropion and Ethanol, Alone and in Combination, on Human Performance Tests, Subjective Rating Scales, EEG and Autonomic Responses
P02-36UK Completed Investigation of the Effects of Bupropion and Imipramine on the Blood Pressure Response to Tyramine in Man
P02-37UK Completed Comparison of the Effects of Bupropion, Nomifensine, and Dextroamphetamine on Performance Tests, Subjective Scales, Autonomic Responses, and Electroencephalograms in Healthy Human Volunteers
P1653 Completed A single rising dose study of the safety, tolerability, pharmacokinetics & pharmacodynamics of subcutaneous SR90107A/ORG31540 natural pentasaccaride in healthy male volunteers
P2200313 Completed A safety study of a topical corticosteroid cream in pediatric subjects aged 3 years to 5 years 11 months with atopic dermatitis
P2200314 Completed A safety study of a topical corticosteroid cream in pediatric subjects aged 3 months to 35 months with atopic dermatitis
P2200440 Completed A Mult-Center, Open-Label Study to Evaluate Product Duration of Use Experience with Aclometasone Diproprionate Cream
P42-05 Completed A Multicenter, Placebo-Controlled, Parallel-Design, Dose-Response Evaluation of the Safety and Efficacy of Lamotrigine as Add-On Therapy in Epileptic Outpatients with Partial Seizures
P42-06 Completed A Multicenter, Double-Blind, Placebo-Controlled, Add-On, Crossover Study of Lamotrigine in Epileptic Outpatients with Partial Seizures
P42-16 Completed A Multicenter, Placebo-Controlled Parallel-Design, Phase III Evaluation of the Safety of Lamotrigine (LAMICTAL) as Add-On Therapy in Outpatients with Partial Seizures
P66/H73-005 Completed An International, Double-Blind, Controlled Trial Comparing Oral Acyclovir to Oral Valaciclovir for the Treatment of Herpes Zoster in Immunocompetent Patients 50 Years of Age or Older
P66/H73-006 Completed A Multicenter, Double-Blind, Placebo-Controlled Trial Evaluating Oral Valaciclovir for the Treatment of Herpes Zoster in Immunocompetent Patients Less Than 50 Years Old
P66/H73-012 Completed Pharmacokinetic Analysis: Oral 256U87 Safety, Pharmacokinetics, and Prophylaxis of Cytomegalovirus Infection and Disease in Renal Allograft Recipients
P66/H73-012 (CMV Seronegative Recipients) Completed Oral 256U87 (Valaciclovir) Safety, Pharmacokinetics and Suppression of Cytomegalovirus Infection and Disease in Renal Allograft Recipients
P66/H73-012 (CMV Seropositive Recipients) Completed Oral 256U87 (Valaciclovir) Safety, Pharmacokinetics and Suppression of Cytomegalovirus Infection and Disease in Renal Allograft Recipients
P66-09 (123-009) Completed Single-Dose Pharmacokinetics and Safety of Valaciclovir in Volunteers with End-Stage Renal Disease
P66-10 Completed Pharmacokinetics and Safety of Acyclovir and Valaciclovir Following Single and Multiple Oral Administration of Valaciclovir in Geriatric Volunteers With and Without Concomitant Diuretic Therapy
P66-H73-003 Completed A Comparative Trial of Valacyclovir and Acyclovir for the Treatment of First-Episode Genital Herpes Infection
PAD20001 Completed A multi-center, three-staged with interim analyses, parallel, randomized, double-blind, fenofibrate-and placebo-controlled proof of concept and dose-response evaluation of the safety, tolerability, and effects on plasma high-density lipoprotein cholesterol (HDLc) and triglycerides of eight weeks treatment with GW501516 in otherwise healthy patients with low HDLc, mildly to moderately elevated triglycerides, and normal low-density lipoprotein cholesterol (LDLc)
PAR MDSA/29060/III/86/1182 Completed A Study to Assess the Tolerance of Paroxetine in Short and Long Term Therapy and to Assess the Efficacy and Tolerance in a Subset of Patients in whom Previous Antidepressant Therapy had Failed. An Open Study
PAR03_001 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.